Pharmaceutical Executive-05-01-2018

Pharmaceutical Executive

In its 12th annual feature, Pharm Exec builds on the revamped approach it introduced last year in spotlighting notable biopharma brands, profiling a new round of products that are making waves in five key areas in healthcare and R&D.

Pharmaceutical Executive

Pair of EU meetings, while well-meant, offered little action and beg the question-what’s the true merit in working together?

Columns
Pharmaceutical Executive

May 09, 2018

Pharm Exec interviews the FDA commissioner, who is building support by combating opioid abuse and advancing innovation.

Pharmaceutical Executive

Meeting the stringent cloud compliance and regulatory requirements in pharma. 

Pharmaceutical Executive
From the Editor

May 08, 2018

Amid new efforts to inspire more physicians to engage their patients about clinical research, turning that vision into tangible gains in trial participation remains tricky.

Pharmaceutical Executive

A former biology major, biotech investment banker, and venture capitalist, Tim Sullivan brings that sought-after melding of business and scientific perspectives to his role as chief financial officer for Apellis, a clinical-stage drug company hopeful of ushering in novel protein inhibitors form autoimmune disease.

Pharmaceutical Executive

With digitalization enabling patient engagement with their own health experience more than ever before, two critical elements will steer pharma’s advertising path.

Pharmaceutical Executive

Overcoming the challenges of digital brand management will involve choices in spending and channels.

Pharmaceutical Executive

How “patient influencers” look beyond price to help the industry evaluate newly-launched brands.

Pharmaceutical Executive
Columns

May 05, 2018

Charting the course that has led to payer vertical integration and what it may mean for pharma manufacturers.

Pharmaceutical Executive

It’s just as hard to make treatments look good to physicians as it is patients-but communicating through entertainment can be done.

Special Sponsored Section
Pharmaceutical Executive

May 01, 2018

Away from the glare of publicity, a tranche of bold reforms in Canada, aimed at harmonizing the national health system and delivering value for money, are fast nearing completion.

Issue PDF
Pharmaceutical Executive

May 01, 2018

Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.